ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $928,606 | -0.2% | 57,145 | +13.6% | 0.00% | 0.0% |
| Q1 2024 | $930,065 | -7.8% | 50,301 | +56.1% | 0.00% | -33.3% |
| Q4 2023 | $1,008,808 | -38.9% | 32,220 | -59.3% | 0.00% | -40.0% |
| Q3 2023 | $1,651,779 | -75.1% | 79,260 | -71.4% | 0.01% | -75.0% |
| Q2 2023 | $6,638,845 | -47.9% | 277,196 | -59.0% | 0.02% | -55.6% |
| Q1 2023 | $12,737,225 | -16.3% | 676,792 | -29.2% | 0.04% | -18.2% |
| Q4 2022 | $15,214,553 | +3914.4% | 955,688 | +4022.0% | 0.06% | +2650.0% |
| Q3 2022 | $379,000 | -19.4% | 23,185 | +19.3% | 0.00% | 0.0% |
| Q1 2022 | $470,000 | -82.5% | 19,436 | -61.2% | 0.00% | -83.3% |
| Q4 2020 | $2,680,000 | +9.7% | 50,129 | -15.4% | 0.01% | +20.0% |
| Q3 2020 | $2,444,000 | -56.3% | 59,260 | -48.7% | 0.01% | -64.3% |
| Q2 2020 | $5,594,000 | +167.0% | 115,420 | +132.8% | 0.03% | +100.0% |
| Q1 2020 | $2,095,000 | -43.9% | 49,585 | -43.2% | 0.01% | +16.7% |
| Q4 2019 | $3,735,000 | +188.6% | 87,317 | +81.1% | 0.01% | +140.0% |
| Q1 2019 | $1,294,000 | +60.5% | 48,215 | -3.3% | 0.01% | +25.0% |
| Q4 2018 | $806,000 | +467.6% | 49,861 | +689.7% | 0.00% | +300.0% |
| Q1 2018 | $142,000 | – | 6,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |